In a multivariable logistic regression analysis, prescribing for RTIs was independently and positively associated with COPD/chronic lung disease, purulent/bloody sputum, an abnormal chest X-ray, and CRP ≥ 100 mg/L. The gene discussed is CRP; the disease is chronic lung disease.